RADX
Radiopharm Theranostics Limited American Depositary Shares
RADX
RADX
4 hedge funds and large institutions have $1.94M invested in Radiopharm Theranostics Limited American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
$841K |
| 2 |
AAA
Affinity Asset Advisors
New York
|
$684K |
| 3 |
RP
Regal Partners
Sydney, NSW,
Australia
|
$408K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$5.91K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
1
Silverarc Capital Management
Boston,
Massachusetts
| $841K | +$841K | +187,406 | New |
|
|
AAA
2
Affinity Asset Advisors
New York
| $684K | +$684K | +156,171 | New |
|
|
RP
3
Regal Partners
Sydney, NSW,
Australia
| $408K | +$408K | +90,909 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $5.91K | +$5.91K | +1,317 | New |
|